Astec LifeSciences Limited has informed the Exchange that Record date for the purpose of is 26-Jul-2026.
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250 and 2.2 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Astec LifeSciences Limited's Board approved audited standalone and consolidated financial results for Q4 and FY ended 31st March 2026. Statutory auditors B S R & Co. LLP issued unmodified (clean) opinions on both sets of results, confirming true and fair view. The company fixed its 32nd AGM for 31st July 2026 with book closure from 26th to 30th July 2026. The Board also approved seeking shareholder approval via postal ballot for director appointments (including Mr. Arijit Mukherjee as Executive Director/COO, Mr. Vishal Sharma, Mr. Burjis N. Godrej as Non-Executive Directors, and Mr. Mathew Eipe as Independent Director), as well as approval for entering into Material Related Party Transactions during FY 2026-27.
Clean audit opinions indicate no material concerns with financial reporting. Shareholders will vote on multiple board appointments and related party transaction approvals - the latter requiring special attention as it involves ongoing business relationships that need transparent disclosure.